Technical Analysis for MTNB - Matinas Biopharma Holdings, Inc.

Grade Last Price % Change Price Change
grade C 1.25 -2.34% -0.03
MTNB closed down 2.34 percent on Tuesday, March 19, 2019, on 79 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical MTNB trend table...

Date Alert Name Type % Chg
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 18 20 DMA Support Bullish -2.34%
Mar 18 Wide Bands Range Expansion -2.34%
Mar 15 Bullish Engulfing Bullish -3.85%
Mar 15 Crossed Above 20 DMA Bullish -3.85%
Mar 15 180 Bullish Setup Bullish Swing Setup -3.85%
Mar 15 Pocket Pivot Bullish Swing Setup -3.85%
Mar 15 Volume Surge Other -3.85%
Mar 15 Outside Day Range Expansion -3.85%

Older signals for MTNB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections. Its cochleate delivery technology platform is designed for the targeted delivery of pharmaceuticals directly to the site of infection or inflammation. Its MAT 2203 is an oral formulation of a spectrum anti-fungal drug called amphotericin B, which uses its cochleate delivery technology. Its MAT2501 is an orally administered, encochleated formulation of the spectrum aminoglycoside antibiotic amikacin, which may be used to treat different types of multidrug-resistant bacteria, including non-tubercular mycobacterial infections (NTM), as well as various multidrug-resistant gram negative and intracellular bacterial infections.
Medicine Biopharmaceutical Medical Specialties Pharmaceuticals Drugs Inflammation Infection Antibiotic Antimicrobial Resistance Multiple Drug Resistance Amphotericin B Serious And Life Threatening Infections
Is MTNB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.5
52 Week Low 0.32
Average Volume 1,273,444
200-Day Moving Average 0.7195
50-Day Moving Average 1.0918
20-Day Moving Average 1.2385
10-Day Moving Average 1.252
Average True Range 0.1188
ADX 33.06
+DI 20.2529
-DI 11.8699
Chandelier Exit (Long, 3 ATRs ) 1.1436
Chandelier Exit (Short, 3 ATRs ) 1.3384
Upper Bollinger Band 1.4602
Lower Bollinger Band 1.0168
Percent B (%b) 0.53
BandWidth 35.801373
MACD Line 0.0518
MACD Signal Line 0.0649
MACD Histogram -0.0131
Fundamentals Value
Market Cap 114.97 Million
Num Shares 92 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -2.72
Price-to-Sales 1705.03
Price-to-Book 10.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.40
Resistance 3 (R3) 1.41 1.38 1.38
Resistance 2 (R2) 1.38 1.34 1.37 1.37
Resistance 1 (R1) 1.31 1.31 1.30 1.30 1.36
Pivot Point 1.28 1.28 1.27 1.27 1.28
Support 1 (S1) 1.21 1.24 1.20 1.20 1.14
Support 2 (S2) 1.18 1.21 1.17 1.13
Support 3 (S3) 1.11 1.18 1.13
Support 4 (S4) 1.10